Adage Capital Partners Gp, L.L.C. F Star Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.18 - $6.39 $1.96 Million - $5.75 Million	-900,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.2 - $8.42 $520,000 - $842,000	100,000 Added 12.5%	900,000 $6.59 Million
Q2 2021 Aug 16, 2021	BUY	$6.57 - $10.71 $5.26 Million - $8.57 Million	800,000 New	800,000 $6.87 Million

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.